This invention relates generally to masks for use in medical and other clinical applications, and more particularly to a multi-chamber mask and method of forming the same.
Many people experience breathing problems on a recurring basis, which often results in sleep disordered breathing (i.e., difficulty sleeping, snoring, or other more serious conditions such as obstructive sleep apnea). As technology advances, people with such breathing problems demand increased performance and comfort. Previous devices for improving a user's breathing have included face masks, nose masks, or nasal inserts that help deliver air to the user's nose at positive pressure. These devices help force open the user's breathing passage and thereby improve the user's breathing. However, previous devices have often provided an inadequate fit and have often failed to adequately prevent leakage. In addition, previous devices have caused discomfort for users and thus have been poorly suited for treating breathing problems such as sleep disordered breathing.
According to one embodiment, a multi-chamber mask includes a shell and a partition. The shell is adapted to cover portions of a user's face including the user's mouth and at least portions of the user's nose including the nostrils, the shell adapted to contact the user's face surrounding the covered portions of the user's face to substantially prevent gas from escaping between the shell and the contacted portions of the user's face, and the shell is adapted to couple to a gas supply source. The partition is coupled to the shell and cooperates with the shell to define a first chamber and a second chamber, the first chamber adapted to be positioned proximate the user's nose to direct inflow of gas from the gas supply source to the user's nasal passages, the second chamber adapted to be positioned proximate the user's mouth to restrict outflow of gas from the user's mouth in response to inflow of gas from the gas supply source to the user's nasal passages, the partition adapted to restrict flow of gas between the first and the second chamber.
According to another embodiment a method of forming a multi-chamber mask includes providing a first layer of deformable material covering portions of a facial surface, the facial surface representing physical features of a user's face, the covered portions of the facial surface portions corresponding to the user's mouth and at least a portion of the user's nose including the nostrils. One or more openings are provided in the first layer of deformable material corresponding to the user's mouth and nostrils. One or more spacers are provided covering at least a portion of the facial surface corresponding to the user's mouth. A second layer of deformable material is provided over the one or more spacers and at least a portion of the first layer. A partition is provided between the first and second layers of deformable material adapted to cooperate with the first and second layers of deformable material to define a first chamber and a second chamber, the first chamber adapted to be positioned proximate the user's nose to direct inflow of gas from a gas supply source to the user's nasal passages, the second chamber adapted to be positioned proximate the user's mouth to restrict outflow of gas from the user's mouth in response to inflow of gas from the gas supply source to the user's nasal passages, the partition adapted to restrict flow of gas between the first and the second chamber. The first layer of deformable material is coupled to the second layer of deformable material, with the partition between the first and second layers of deformable material, to form the multi-chamber mask.
Certain embodiments may provide one or more technical advantages. For example, in certain embodiments, a single multi-chamber mask allows a gas to flow to the nasal passages, while at the same time reducing or preventing the gas form flowing to the mouth. Certain embodiments may allow the mask to connect to an oral appliance or provide access to an oral appliance through an opening in the mask. Certain embodiments may provide a custom-fitted mask that conforms substantially optimally to a user's unique facial structure and features. Certain embodiments may provide improved fit, increased comfort, reduced leakage, and improved performance, whether for treating sleep disordered breathing, for administering anesthesia, or for any other suitable purpose for which the multi-chamber mask is used. Certain embodiments may provide all, some, or none of these advantages. Certain embodiments may provide one or more other technical advantages, one or more of which may be apparent to those skilled in the art from the figures, descriptions, and claims included herein.
For a more complete understanding of the present invention and its advantages, reference is now made to the following description, taken in conjunction with the accompanying drawings, in which:
In certain embodiments, multi-chamber mask 100 is custom formed to fit the user's unique facial structure and features, including at least the portion of the user's face surrounding the user's mouth and nostrils. This may allow multi-chamber mask 100 to provide reduced leakage, increased comfort, and better performance.
In certain embodiments, multi-chamber mask 100 is formed from a first layer 102, a second layer 104, and a partition 106. When assembled, first layer 102, second layer 104, and partition 106 define an upper chamber and a lower chamber. In certain embodiments, first layer 102 operates to form a seal between multi-chamber mask 100 and the user's face to substantially prevent leakage of gas between multi-chamber mask 100 and the user's face. Similarly, second layer 104 is coupled to first layer 102 to substantially prevent leakage of gas between second layer 104 and first layer 102.
Multi-chamber mask 100 may be secured to the user's face in any appropriate manner. In certain embodiments, multi-chamber mask 100 may include buckles, snaps, or other devices to couple multi-chamber mask 100 to one or more straps, which may help secure multi-chamber mask 100 to the user's face during use. In certain embodiments, as described more fully below, multi-chamber mask 100 may be secured in cooperation with an oral appliance, with or without straps.
In operation, multi-chamber mask 100 may be positioned such that gas from gas supply source 300 flows through fitting 200, through the upper chamber of multi-chamber mask 100, and through the user's nasal passages to the user's breathing passage. In certain embodiments, partition 106 may substantially prevent gas from gas supply source 300 from flowing into the lower chamber of multi-chamber mask 100, thereby substantially preventing the gas from entering the mouth of the user. However, gas may flow out of the user's mouth and into the lower chamber of multi-chamber mask 100. The use of multi-chamber mask 100, having an upper chamber and a lower chamber, may allow for improved performance when multi-chamber mask 100 is used for treating sleep disordered breathing, for administering anesthesia, or for any other suitable purpose for which multi-chamber mask 100 is used.
In certain embodiments, as shown in
In certain embodiments, first layer 102 may include a deformable material such as a suitable thermoplastic polymer and any suitable fillers, stabilizers, coloring agents, antioxidants, antimicrobial agents, or other materials. In certain embodiments, first layer 102 may include a light curing material such as the material sold under the name TRIAD by DENSTSPLY INTERNATIONAL, INC. Such materials are well known in various contexts to those skilled in the art.
In one particular embodiment, first layer 102 may include, possibly in addition to one or more other materials, one or more of the polycaprolactone polymers or other aliphatic polyesters described in U.S. Pat. Nos. 4,784,123 and 5,112,225 and product literature of UNION CARBIDE CORPORATION. One or more such polycaprolactone polymers may have the formula:
where R is an aliphatic hydrocarbon and n may range between approximately 300 to approximately 650. The TONE polycaprolactone polymers are described in U.S. Pat. Nos. 4,784,123 and 5,112,225 and product literature of UNION CARBIDE CORPORATION as including homopolymers, block copolymers, graft copolymers, or other polymers containing epsilon-caprolactone. Polymerization may be initiated using a diol, for example and without limitation, ethylene glycol, diethylene glycol, neopentyl glycol, butane diol, hexane diol, or any other appropriate diol. The diol may have the formula:
HO—R—OH (2)
where R is an aliphatic hydrocarbon. Where first layer 102 includes one or more polycaprolactone polymers, any suitable polycaprolactone polymer or polymers may be used. In general, polycaprolactone polymers may display desirable dimensional stability and thermoplasticity during cooling, biocompatibility, and a variety of other characteristics making them suitable for use in forming first layer 102, as described herein.
In another particular embodiment, first layer 102 may begin as a thin sheet of deformable material that is substantially flat except for one or more depressions such as a depression sufficient to accommodate a generic user's nose, including at least the portion of the generic user's nose surrounding the user's nostrils. Alternatively, first layer 102 may begin as a thin sheet of deformable material that is substantially flat over its entire surface and does not include any depressions. Thin sheets of an appropriate deformable material may be obtained, for example, from CHESAPEAKE MEDICAL PRODUCTS, INC. In all cases, first layer 102 may include pre-formed holes positioned according to the position of a generic user's nostrils. First layer 102 may be formed using an injection molding process (i.e., deformable material is placed into an injection molding machine while in a liquid state), using a pressing process (i.e., deformable material is placed into a press while in a deformable state), or using any other suitable technique. First layer 102 may be sized for various classes of generic users, for example, large for men, medium for women, and small for children. In one embodiment, first layer 102 may be mass produced quickly, inexpensively, and with high quality and uniformity.
Prior to applying first layer 102 to facial surface 400, first layer 102 is placed in a deformable state. For example, where first layer 102 includes one or more polycaprolactone polymers, first layer 102 may be heated in a microwave oven, in water or other non-solvent neutral liquid, or in any other suitable manner to between approximately 140° F. and approximately 180° F. so as to place first layer 102 in a deformable state. While in a deformable state, first layer 102 is brought in contact with facial surface 400, including at least the portion of facial surface 400 corresponding to the area surrounding the user's mouth and nostrils. First layer 102 is then pressed against or otherwise allowed to conform to the shape of facial surface 400. As the deformable material cools and hardens, first layer 102 solidifies and will substantially retain the shape of facial surface 400.
As shown in
In certain embodiments, first layer 102 may have portions corresponding to the user's nostrils removed to form one or more nostril openings 112. Similar to the removal of the portion corresponding to the user's mouth described above, the removal of these portions of first layer 102 may be performed prior to or following application of first layer 102 to facial surface 400. The removal of these portions may also be performed before, during, or after first layer 102 is placed in a deformable state. Alternatively, rather than removing these portions to form one or more nostril openings 112, first layer 102 may be initially formed having one or more nostril openings 112 such that no material needs to be removed.
As shown in
As shown in
In certain embodiments, prior to applying second layer 104 to cover spacer 500 and at least a portion of first layer 102, second layer 104 is placed in a deformable state. For example, where the deformable material of second layer 104 includes one or more polycaprolactone polymers, second layer 104 may be heated in a microwave oven, in water or other non-solvent neutral liquid, or in any other suitable manner to between approximately 140° F. and approximately 180° F. so as to place second layer 104 in a deformable state. While in a deformable state, second layer 104 is brought in contact with spacer 500 and first layer 102. Second layer 104 is then pressed against or otherwise allowed to conform to the shape of spacer 500 and first layer 102. As the deformable material cools and hardens, second layer 104 solidifies and will substantially retain the shape of at least a portion of spacer 500 and first layer 102.
As shown in
In certain embodiments, partition 106 may be positioned between the portions of multi-chamber mask 100 corresponding to a user's nostrils and mouth. Following assembly, partition 106, together with first layer 102 and second layer 104, defines upper chamber 108 and lower chamber 110. The components of multi-chamber mask 100 may be assembled and coupled to one another using a suitable adhesive or any other suitable method. For example, a suitable deformable thermoplastic material may be placed in a deformable state and applied to the areas of contact between first layer 102, second layer 104, and partition 106. The deformable thermoplastic material may then be allowed to harden, thereby fusing, bonding, or otherwise coupling first layer 102, second layer 104, and partition 106.
In certain embodiments, a portion of second layer 104 may be removed to form an opening in a position corresponding to the desired location of fitting 200. The removal of this portion of second layer 104 may be performed prior to or following the application of second layer 104 to cover spacer 500 and at least a portion of first layer 102. The removal of this portion of second layer 104 may also be performed prior to or following the assembly of multi-chamber mask 100. The opening may be positioned in any location suitable to allow gas from gas supply source 300 to flow through fitting 200 into upper chamber 108. Fitting 200 may then be affixed to second layer 104, such that fitting 200 fits into or around this opening in second layer 104.
Although the present invention has been described in several embodiments, a plenitude of modifications may be suggested to one skilled in the art, and it is intended that the present invention encompass such modifications as fall within the scope of the appended claims.
This application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Application Ser. No. 60/698,181 filed Jul. 11, 2005.
Number | Name | Date | Kind |
---|---|---|---|
339334 | Searle | Apr 1886 | A |
690663 | Pratt | Jan 1902 | A |
746869 | Moulton | Dec 1903 | A |
774446 | Moulton | Nov 1904 | A |
781516 | Guthrie, Jr. | Jan 1905 | A |
885196 | Steil | Apr 1908 | A |
893213 | Whiteway | Jul 1908 | A |
996783 | Moreau | Jul 1911 | A |
1483694 | Stukey | Feb 1924 | A |
1675202 | Warne | Jun 1928 | A |
1679748 | Stratton | Aug 1928 | A |
2178128 | Waite | Oct 1939 | A |
2383649 | Heidbrink | Aug 1945 | A |
2424533 | Faires | Jul 1947 | A |
2505028 | Boeger | Apr 1950 | A |
2521084 | Oberto | Sep 1950 | A |
2574623 | Clyde | Nov 1951 | A |
2627268 | Leppich | Feb 1953 | A |
2671446 | Mann | Mar 1954 | A |
2867212 | Nunn, Jr. | Jan 1959 | A |
2882893 | Godfroy | Apr 1959 | A |
2917045 | Schildknecht et al. | Dec 1959 | A |
2977636 | McGuire | Apr 1961 | A |
3037501 | Miller | Jun 1962 | A |
3330274 | Bennett | Jul 1967 | A |
3658058 | Neidhart et al. | Apr 1972 | A |
3695265 | Brevik | Oct 1972 | A |
3845768 | Garrahan | Nov 1974 | A |
4050457 | Davidson | Sep 1977 | A |
4233972 | Hauff et al. | Nov 1980 | A |
4258710 | Reber | Mar 1981 | A |
4289127 | Nelson | Sep 1981 | A |
4294243 | Ernsting et al. | Oct 1981 | A |
4345592 | Giorgini et al. | Aug 1982 | A |
4345593 | Sullivan | Aug 1982 | A |
4392490 | Mattingly et al. | Jul 1983 | A |
4397701 | Johnson et al. | Aug 1983 | A |
4454090 | Saumell | Jun 1984 | A |
4470413 | Warncke | Sep 1984 | A |
4655213 | Rapoport et al. | Apr 1987 | A |
4706683 | Chilton et al. | Nov 1987 | A |
4784123 | Robeson | Nov 1988 | A |
4858605 | Levy | Aug 1989 | A |
4858606 | Hamlin | Aug 1989 | A |
4862903 | Campbell | Sep 1989 | A |
4870962 | Sitnik | Oct 1989 | A |
4886056 | Simpson | Dec 1989 | A |
4906234 | Voychehovski | Mar 1990 | A |
4919128 | Kopala et al. | Apr 1990 | A |
4941212 | Liff | Jul 1990 | A |
5042478 | Kopala et al. | Aug 1991 | A |
5062421 | Burns et al. | Nov 1991 | A |
5065756 | Rapoport | Nov 1991 | A |
5066231 | Oxman et al. | Nov 1991 | A |
5193532 | Moa et al. | Mar 1993 | A |
5233978 | Callaway | Aug 1993 | A |
5243971 | Sullivan et al. | Sep 1993 | A |
5243972 | Huang | Sep 1993 | A |
5245995 | Sullivan et al. | Sep 1993 | A |
5265595 | Rudolph | Nov 1993 | A |
5267557 | Her-Mou | Dec 1993 | A |
5392773 | Bertrand | Feb 1995 | A |
5456264 | Series et al. | Oct 1995 | A |
5458137 | Axe et al. | Oct 1995 | A |
5474060 | Evans | Dec 1995 | A |
5477850 | Zegler et al. | Dec 1995 | A |
5503146 | Froehlich et al. | Apr 1996 | A |
5517983 | Deighan et al. | May 1996 | A |
5537994 | Thornton | Jul 1996 | A |
5537999 | Dearman et al. | Jul 1996 | A |
5538000 | Rudolph | Jul 1996 | A |
5538014 | Wilson et al. | Jul 1996 | A |
5540223 | Starr et al. | Jul 1996 | A |
5551419 | Froehlich et al. | Sep 1996 | A |
5558090 | James | Sep 1996 | A |
RE35339 | Rapoport | Oct 1996 | E |
5560354 | Berthon-Jones et al. | Oct 1996 | A |
5592935 | Elstran et al. | Jan 1997 | A |
5611485 | Davis | Mar 1997 | A |
5657751 | Karr, Jr. | Aug 1997 | A |
5657752 | Landis et al. | Aug 1997 | A |
5662101 | Ogden et al. | Sep 1997 | A |
5676133 | Hickle et al. | Oct 1997 | A |
5687715 | Landis et al. | Nov 1997 | A |
5713349 | Keaney | Feb 1998 | A |
5718244 | Thornton | Feb 1998 | A |
5718500 | Vinci guerra et al. | Feb 1998 | A |
5720280 | Elstran et al. | Feb 1998 | A |
5724965 | Handke et al. | Mar 1998 | A |
5746201 | Kidd | May 1998 | A |
5752510 | Goldstein | May 1998 | A |
5807100 | Thornton | Sep 1998 | A |
5810749 | Maas | Sep 1998 | A |
5832918 | Pantino | Nov 1998 | A |
5846082 | Thornton | Dec 1998 | A |
5887587 | Groenke | Mar 1999 | A |
5954048 | Thornton | Sep 1999 | A |
5983892 | Thornton | Nov 1999 | A |
5988166 | Hayek | Nov 1999 | A |
6012455 | Goldstein | Jan 2000 | A |
6083442 | Gabilly | Jul 2000 | A |
6119694 | Correa et al. | Sep 2000 | A |
6123071 | Berthon-Jones et al. | Sep 2000 | A |
6209542 | Thornton | Apr 2001 | B1 |
6263871 | Brown et al. | Jul 2001 | B1 |
D448473 | Barnett et al. | Sep 2001 | S |
6374824 | Thornton | Apr 2002 | B1 |
6405729 | Thornton | Jun 2002 | B1 |
6412488 | Barnett et al. | Jul 2002 | B1 |
6464924 | Thornton | Oct 2002 | B1 |
6494206 | Bergamaschi et al. | Dec 2002 | B1 |
6571798 | Thornton | Jun 2003 | B1 |
6645413 | Jacobs | Nov 2003 | B2 |
6675802 | Thornton | Jan 2004 | B1 |
6758212 | Swann | Jul 2004 | B2 |
6857428 | Thornton | Feb 2005 | B2 |
6877513 | Scarberry et al. | Apr 2005 | B2 |
7077138 | Bateman et al. | Jul 2006 | B2 |
20020129818 | Morgan et al. | Sep 2002 | A1 |
20020139366 | Gaschke | Oct 2002 | A1 |
20040079374 | Thornton | Apr 2004 | A1 |
20040226563 | Xu et al. | Nov 2004 | A1 |
20040237965 | Bibi et al. | Dec 2004 | A1 |
20050016544 | Thornton | Jan 2005 | A1 |
20060005837 | Thornton | Jan 2006 | A1 |
20060124131 | Chandran et al. | Jun 2006 | A1 |
Number | Date | Country |
---|---|---|
156627 | Dec 1904 | DE |
35 43 931 | Jun 1987 | DE |
37 07 952 | Sep 1988 | DE |
37 19 009 | Dec 1988 | DE |
44 38 512 | May 1996 | DE |
198 46 686 | Jul 1999 | DE |
2 658 725 | Aug 1991 | FR |
2 731 624 | Sep 1996 | FR |
2731624 | Sep 1996 | FR |
WO 9820924 | May 1998 | WO |
WO 9846177 | Oct 1998 | WO |
Number | Date | Country | |
---|---|---|---|
20070006879 A1 | Jan 2007 | US |
Number | Date | Country | |
---|---|---|---|
60698181 | Jul 2005 | US |